Davide Bimbatti

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

Matteo Santoni, Sebastiano Buti, Zin Myint et al. · European Urology Oncology · 2023 · 77 citations · Full text

Medicine, Immunology, Oncology +14

Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer

Roberto Iacovelli, Chiara Ciccarese, Claudia Mosillo et al. · Targeted Oncology · 2018 · 27 citations

Medicine, Oncology, Urology +12

Cabozantinib‐related cardiotoxicity: a prospective analysis in a <i>real‐world</i> cohort of metastatic renal cell carcinoma patients

Roberto Iacovelli, Chiara Ciccarese, Giuseppe Fornarini et al. · British Journal of Clinical Pharmacology · 2019 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer

Giuseppe Luigi Banna, Valeria Urzia, Chiara Benanti et al. · Supportive Care in Cancer · 2020 · 25 citations

Medicine, Oncology, Pharmacotherapy +12

Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach

Michelangelo Fiorentino, Elisa Gruppioni, Francesco Massari et al. · Oncotarget · 2016 · 24 citations · Full text

Medicine, Oncology, Pathology +16